Beckman Coulter Receives the US FDA 510(k) Clearance For DxC 500i Clinical Analyzer
Shots:
- The US FDA granted 510(k) Clearance to the DxC 500i Clinical Analyzer, an integrated clinical chemistry and immunoassay analyzer capable of processing up to 800 clinical chemistry and 100 immunoassay tests per hour
- The DxC 500i analyzer leverages Beckman’s previous model DxC 500 AU technology within its clinical chemistry capabilities, including its Six Sigma performance, and introduces FlexMode operations for prioritizing immunoassay and chemistry tests based on sample urgency
- The DxC 500i analyzer has been available in CE mark-accepting countries since July 2024
Ref: Beckman Coulter | Image: Beckman Coulter
Related News:- The US FDA Grants 510(k) Clearance to Zimmer Biomet’s Persona Revision SoluTion Femur
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
Click here to read the full press release
Tags
Ridhi is an avid secondary researcher who follows trends in the biopharmaceutical and healthcare sectors to curate engaging content for the global audience. She works as a news editor at PharmaShots and loves to read books and explore new destinations.
